SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing heavy social media attention as investors anticipate imminent clinical milestones from the Phase 3 REGAL trial for its AML treatment. The community is actively debating the stock's high short interest and potential for a significant squeeze, while others remain skeptical about trial design and the company's long-term commercial outlook.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is experiencing high-volume discussions driven by a mix of long-term investor anticipation regarding a potential eBay acquisition and significant skepticism toward social media figures accused of promoting the stock for personal gain. While bulls highlight improving financial guidance and fundamental turnaround efforts, the community remains deeply polarized by the lack of immediate price catalysts and the persistent presence of speculative meme stock comparisons.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is experiencing intense community focus as market participants debate its long-term potential following a move to multi-year lows, with many comparing its transparent, capped supply to other assets facing volatility. Investors are actively discussing potential accumulation zones and historical patterns, hoping that increasing transaction activity and network development will trigger a significant recovery.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility and heavy trading volume as investors debate the impact of index rebalancing and lingering buyout rumors. Community sentiment remains polarized, with many shareholders expressing frustration over stagnant performance and leadership, while others point to the company's strong revenue and potential pipeline catalysts as reasons to hold.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant community discussion as investors weigh the stock's long-term potential as an enterprise AI workflow leader against recent price volatility and sector-wide software pressure. While retail sentiment remains split between concerns over enterprise software valuation and bullish conviction in the companys strong renewal rates and AI-driven growth, the stock is being actively monitored for signs of a technical reversal and potential rotation into SaaS assets.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investors debate the impact of newly unveiled drone technology alongside ongoing frustration regarding a lack of significant contract announcements. While the community remains divided over potential government support and the stock's future performance, discussions are heavily focused on the company's ability to transition from a R&D-focused entity into a scalable defense supplier.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is currently a primary focus for traders seeking to leverage market volatility, with the community actively debating whether the underlying asset is facing a systemic decline or a temporary correction. Investors are utilizing algorithmic signals and technical indicators to time entry points, heavily favoring swing trading strategies to capitalize on rapid price fluctuations and potential further downside in the crypto-related equity sector.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing a period of heightened interest and intense debate, driven by a recent T-cell engager partnership with Jazz Pharmaceuticals and growing anticipation for Phase 2 clinical trial results. While the community is actively debating the stock's long-term potential as an AI-driven drug discovery play versus its history of price underperformance, significant discussion centers on high short interest, institutional accumulation, and the potential for a technical breakout on heavy volume.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is trending due to volatile price action and intense community speculation regarding potential short squeezes and upcoming token movements. While some investors remain optimistic about a sustained rally, others are actively debating whether the current activity is a recurring pump-and-dump cycle.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors await the upcoming administrative rescheduling hearing, which community members hope will serve as a definitive catalyst for sector-wide progress. Discussion is heavily focused on the implications of the DEA's hearing on broader federal reform, with many stakeholders actively debating the impact of potential regulatory shifts on the company's long-term growth and market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XBI up 7 percxent since I added to my portfolio and shared 
 
now $XLV coming to the party after being a dog the last year 
 
it was the BEST EVER relaive week for healtcare relative to $SPY  
 
https://x.com/ThierryBorgeat/status/2071315993649934707 
 
the narrative is key and i assume it will be  - &#39;look how much these companies can save deploying ai to fast track research yada yada yada and a lot of this will be true. 
 
I chose index because I have no clue how to pick stocks in this sector wiuth conviction other than Eli Lily with the clear lead in fat pills/needles (I am a customer). 
 
so what happened last week 
 
$LLY all time high, $JNJ all time high and Merck near one. 
 
the degenerates will  surely learn the tickers if the priuces keep going up as they did with NFT&#39;s and crypto and ai and space 
 
Im old and boring for now with the diversified index 
 
Genomics breaking out too

Bill smith

Blanco

Brock Harrison

21Mark

Nosh

MRTunity

Health Care strikes BACK!For two years, owning healthcare felt like punishment.The whole sector bled relative to the S&P while money piled into chips and AI. The XLV/SPY line fell to a quarter-century low. Doctors, drugs, and diagnostics, the stuff that keeps people alive,... pic.twitter.com/52vp4YKu44

X (Formerly Twitter)

Thierry from arvy 🇨🇭 on X (formerly Twitter): "Health Care strikes BACK!For two years, owning healthcare felt like punishment.The whole sector bled relative to the S&P while money piled into chips and AI. The XLV/SPY line fell to a quarter-century low....

StockTwits Web

SPDR S&P Biotech ETF

Howard Lindzon

Health Care Select Sector SPDR Fund

Lilly(Eli) & Co

Johnson & Johnson

 up 7 percxent since I added to my portfolio and shared 
 
now 

 coming to the party after being a dog the last year 
 
it was the BEST EVER relaive week for healtcare relative to 

 
 
the narrative is key and i assume it will be  - 'look how much these companies can save deploying ai to fast track research yada yada yada and a lot of this will be true. 
 
I chose index because I have no clue how to pick stocks in this sector wiuth conviction other than Eli Lily with the clear lead in fat pills/needles (I am a customer). 
 
so what happened last week 
 


 all time high and Merck near one. 
 
the degenerates will  surely learn the tickers if the priuces keep going up as they did with NFT's and crypto and ai and space 
 
Im old and boring for now with the diversified index 
 
Genomics breaking out too